செயலிழக்க செங் ஹாங் காங் பட்டியலிடப்பட்டுள்ளது பயோடெக் குறியீட்டு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from செயலிழக்க செங் ஹாங் காங் பட்டியலிடப்பட்டுள்ளது பயோடெக் குறியீட்டு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In செயலிழக்க செங் ஹாங் காங் பட்டியலிடப்பட்டுள்ளது பயோடெக் குறியீட்டு Today - Breaking & Trending Today

TodayIR: Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Index-es Including the Hang Seng Composite Index


(2)
DJ EQS-News: Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Index-es Including the Hang Seng Composite Index EQS-News / 01/03/2021 / 15:36 UTC+8 Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index
Shanghai and Hong Kong, PRC, March 1, 2021 Antengene Corporation Limited ( Antengene , SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and /or best-in-class therapeutics in hematology and oncology, today announced that the company has been selected as a constituent stock of the Hang Seng Composite Index (HSCI), the Hang Seng Stock Connect Hong Kong Index (HSHKI), the Hang Seng Stock Connect Hong Kong MidCap & SmallCap Index (HSHKMS), the Hang Seng Stock Connect Hong Kong SmallCap Index (HSHKS), the Hang Seng SCHK Mainland China Companies Index (HSSCMLC), the Hang Se ....

Hong Kong , South Korea , Kostenloser Wertpapierhandel , Jay Mei , Asia Pacific , Seng Hong Kong , Marketing Press , Mainland China Companies Index , China National Medical Products Administration , Ah Companies Index , Antengene Corporation Limited , Ministry Of Food , Hong Kong Exchange , Constituent Stock , Nine Benchmark , Thematic Index Es Including , Hang Seng Composite Index , Thematic Indexes Including , Small Cap Index , Hang Seng , China Companies Index , Hang Seng Healthcare Index , Hang Seng Hong Kong Listed Biotech Index , Hang Seng Small Cap , Hang Seng Family , Main Board ,

Ascentage Pharma Officially Included in Shenzhen-Hong Kong Stock Connect Program


Search jobs
Ascentage Pharma Officially Included in Shenzhen-Hong Kong Stock Connect Program
SUZHOU, China and ROCKVILLE, Md., Dec. 30, 2020 /PRNewswire/ Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company was officially included into the Shenzhen-Hong Kong Stock Connect program (the Hong Kong Stock Connect ). This was officially announced by the Shenzhen Stock Exchange ( SZSE ) on December 25, 2020, which has been effective since December 28, 2020. This inclusion is the very first arrangement for the eligible pre-revenue biotech companies listed under Chapter 18A of Hong Kong s Main Board Listing Rules, and complied with the conditions for the inclusion in the Hong Kong Stock Connect. ....

Hong Kong , Western Australia , Dajun Yang , Ascentage Pharma , Seng Hong Kong , Prnewswire Ascentage Pharma , Shenzhen Stock Exchange , National Medical Products Administration , Drug Administration , Shenzhen Hong Kong Stock Connect , Kong Stock , Main Board Listing Rules , Hong Kong Stock , Hong Kong Stock Connect , Shenzhen Stock , Stock Connect , China Mainland , Mainland China , New Drug Application , Orphan Drug Designation , Hang Seng Composite Index , Hang Seng Hong Kong Listed Biotech Index , Hang Seng Healthcare Index , Hang Seng Index , Main Board , Stock Exchange ,